Andrew Arno
CIK 1472122 · last filed 2026-03-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$372.8K
Companies
6
Total Filings
59
Lifetime Open-Market Net
$618.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VTAK | Director | — | $1.05 | — | $0 | 3 | 2026-03-30 |
| SMSI | Director | 89,882 | $2.88 | $258.4K | $99.5K | 19 | 2026-03-10 |
| XXII | Director | 17,481 | $6.54 | $114.4K | $17.5K | 3 | 2025-11-14 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 144,358 | $3.20 | $461.9K | $480.0K | 20 | 2025-07-03 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Director | 5,000 | — | — | $21.6K | 4 | 2018-06-25 |
| Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Director | — | — | — | $0 | 1 | 2017-04-03 |
Recent Filings · Page 2 of 6
59 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-03 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-22 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-15 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +33,898 | $100.0K | EDGAR |
| 2024-01-17 | SMSI | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-01-08 | XXII | Buy (P) | +100,000 | $17.5K | EDGAR |
| 2023-06-27 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2023-04-05 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | +423,252 | $150.0K | EDGAR |
| 2023-01-31 | SMSI | Grant (A) | +25,000 | $0 | EDGAR |
| 2022-12-28 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +250,000 | $87.9K | EDGAR |
| 2022-08-22 | SMSI | Buy (P) | +27,500 | $64.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.